Skip to main content
Addgene

pCDH-EF1a-eFFly-eGFP
(Plasmid #104834)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 104834 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pCDH-EF1a-MCS-T2A-copGFP
  • Backbone manufacturer
    System Biosciences
  • Backbone size w/o insert (bp) 6481
  • Total vector size (bp) 8842
  • Vector type
    Mammalian Expression, Lentiviral, Luciferase ; eGFP

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert 1

  • Gene/Insert name
    eFFly
  • Insert Size (bp)
    1641

Gene/Insert 2

  • Gene/Insert name
    eGFP

Resource Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCDH-EF1a-eFFly-eGFP was a gift from Irmela Jeremias (Addgene plasmid # 104834 ; http://n2t.net/addgene:104834 ; RRID:Addgene_104834)

  • For your References section:

    Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia. Sandhofer N, Metzeler KH, Rothenberg M, Herold T, Tiedt S, Groiss V, Carlet M, Walter G, Hinrichsen T, Wachter O, Grunert M, Schneider S, Subklewe M, Dufour A, Frohling S, Klein HG, Hiddemann W, Jeremias I, Spiekermann K. Leukemia. 2015 Apr;29(4):828-38. doi: 10.1038/leu.2014.305. Epub 2014 Oct 17. 10.1038/leu.2014.305 PubMed 25322685
Related items:
Commonly requested with: